Literature DB >> 10496441

Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function.

C Briguori1, S Betocchi, M Romano, F Manganelli, M Angela Losi, Q Ciampi, R Gottilla, R Lombardi, M Condorelli, M Chiariello.   

Abstract

Some studies have demonstrated that left ventricular (LV) diastolic function is the principal determinant of impaired exercise capacity in hypertrophic cardiomyopathy (HC). In this study we sought the capability of echocardiographic indexes of diastolic function in predicting exercise capacity in patients with HC. We studied 52 patients with HC while they were not on drugs;12 of them had LV tract obstruction at rest. Diastolic function was assessed by M-mode and Doppler echocardiography by measuring: (1) left atrial fractional shortening, and the slope of posterior aortic wall displacement during early atrial emptying on M-mode left atrial tracing; and (2) Doppler-derived transmitral and pulmonary venous flow velocity indexes. Exercise capacity was assessed by maximum oxygen consumption by cardiopulmonary test during cycloergometer upright exercise. Maximum oxygen consumption correlated with the left atrial fractional shortening (r = 0.63, p <0.001), the slope of posterior aortic wall displacement during early atrial emptying (r = 0.55, p <0.001), age (r = -0.50; p <0.001), pulmonary venous diastolic anterograde velocity (r = 0.41, p <0.01), and the systolic filling fraction (r = -0.43; p <0.01). By stepwise multiple linear regression analysis, left atrial fractional shortening and the pulmonary venous systolic filling fraction were the only determinants of the maximum oxygen consumption (multiple r = 0.70; p <0.001). Exercise capacity did not correlate with Doppler-derived transmitral indexes. Thus, in patients with HC, exercise capacity was determined by passive LV diastolic function, as assessed by the left atrial M-mode and Doppler-derived pulmonary venous flow velocities.

Entities:  

Mesh:

Year:  1999        PMID: 10496441     DOI: 10.1016/s0002-9149(99)00282-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

Review 1.  LV hypertrophy and diastolic heart failure.

Authors:  S Betocchi; O M Hess
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

2.  Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects.

Authors:  Quirino Ciampi; Sandro Betocchi; Anna Violante; Raffaella Lombardi; Maria Angela Losi; Giovanni Storto; Fiore Manganelli; Carlo Gabriele Tocchetti; Mariano Aversa; Elpidio Pezzella; Filippo Finizio; Alberto Cuocolo; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

3.  Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction.

Authors:  M Fassbach; B Schwartzkopff
Journal:  Z Kardiol       Date:  2005-05

4.  Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.

Authors:  Georgios K Efthimiadis; Areti Hitoglou-Makedou; Georgios Giannakoulas; Anastasia Mitakidou; Theodoros Karamitsos; Haralambos Karvounis; Sotirios Mochlas; Ioannis Styliadis; Haris Stefanidis; Georgios Parcharidis; Georgios Louridas
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

5.  Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure.

Authors:  Kurt R Daniel; Gretchen Wells; Kathryn Stewart; Brian Moore; Dalane W Kitzman
Journal:  Congest Heart Fail       Date:  2009 Mar-Apr

6.  Effects of exercise on the duration of diastole and on interventricular phase differences in patients with hypertrophic cardiomyopathy: relationship to cardiac output reserve.

Authors:  Gunnar Plehn; Julia Vormbrock; Axel Meissner; Hans-Joachim Trappe
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

7.  Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study.

Authors:  Damiano Magrì; Piergiuseppe Agostoni; Filippo Maria Cauti; Beatrice Musumeci; Gabriele Egidy Assenza; Carlo Nicola De Cecco; Giuseppe Muscogiuri; Antonello Maruotti; Agnese Ricotta; Erika Pagannone; Laura Marino; Daria Santini; Giulia Proietti; Andrea Serdoz; Francesco Paneni; Massimo Volpe; Camillo Autore
Journal:  Intern Emerg Med       Date:  2012-10-07       Impact factor: 3.397

8.  Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity.

Authors:  Y Matsumura; P M Elliott; M S Virdee; P Sorajja; Y Doi; W J McKenna
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 9.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

10.  Relationship between serum biochemical markers of myocardial fibrosis and diastolic function at rest and with exercise in hypertrophic cardiomyopathy.

Authors:  Chi Young Shim; Jong-Won Ha; Eui-Young Choi; Hyun-Jin Lee; Sun-Ha Moon; Jin-Mi Kim; Se-Joong Rim; Namsik Chung
Journal:  Korean Circ J       Date:  2009-12-30       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.